These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 19286222)

  • 21. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
    Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
    Beck SD; Cheng L; Bihrle R; Donohue JP; Foster RS
    J Urol; 2007 Mar; 177(3):944-6. PubMed ID: 17296383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
    Sexton WJ; Wood CG; Kim R; Pisters LL
    J Urol; 2003 Apr; 169(4):1353-6. PubMed ID: 12629359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant undifferentiated sex cord-stromal testis tumor with brain metastasis: case report.
    Kumaravelu PG; Vella S; Pontes JE; Heath EI
    Urol Oncol; 2008; 26(1):53-5. PubMed ID: 18190831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
    Hermans BP; Sweeney CJ; Foster RS; Einhorn LE; Donohue JP
    J Urol; 2000 Jun; 163(6):1721-4. PubMed ID: 10799168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Stage II testicular seminoma over a period of 40 years.
    Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G
    Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy.
    Prabhu R; Hinerman RW; Indelicato DJ; Morris CG; Werning JW; Vaysberg M; Amdur RJ; Kirwan J; Mendenhall WM
    Am J Clin Oncol; 2009 Aug; 32(4):401-4. PubMed ID: 19398900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?
    Spiess PE; Tannir NM; Tu SM; Brown GA; Liu P; Kamat AM; Wood CG; Evans JG; Pisters LL
    Cancer; 2007 Dec; 110(12):2700-8. PubMed ID: 17948916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
    Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
    J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian sex cord-stromal tumors in children and adolescents.
    Schneider DT; Calaminus G; Harms D; Göbel U;
    J Reprod Med; 2005 Jun; 50(6):439-46. PubMed ID: 16050568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.
    Ray-Coquard I; Weber B; Lotz JP; Tournigand C; Provencal J; Mayeur D; Treilleux I; Paraiso D; Duvillard P; Pujade-Lauraine E;
    Gynecol Oncol; 2010 Oct; 119(1):53-9. PubMed ID: 20580063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
    Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of stage I-IIB nonseminomatous testicular tumors].
    Clemm C; Sauer H; Hartenstein R
    Dtsch Med Wochenschr; 1989 Aug; 114(34):1276-82. PubMed ID: 2475318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postchemotherapy laparoscopic retroperitoneal lymph node dissection: evaluation of complications.
    Permpongkosol S; Lima GC; Warlick CA; Allaf ME; Varkarakis IM; Bagga HS; Kohanim S; Kavoussi LR
    Urology; 2007 Feb; 69(2):361-5. PubMed ID: 17320678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for recurrence and survival in primary vulvar squamous cell cancer.
    Ayhan A; Velipasaoglu M; Salman MC; Guven S; Gultekin M; Bayraktar O
    Acta Obstet Gynecol Scand; 2008; 87(11):1143-9. PubMed ID: 18949585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous testicular tumors].
    Donohue JP; Thornhill JA; Foster RS; Rowland RG; Bihrle R
    Prog Urol; 1991 Jun; 1(3):389-95. PubMed ID: 1844715
    [No Abstract]   [Full Text] [Related]  

  • 37. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
    Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
    BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
    Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
    Divrik RT; Akdoğan B; Ozen H; Zorlu F
    J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.